{
  "metadata": {
    "created_date": "2025-09-19T13:34:56.059764",
    "version": "1.1",
    "description": "Comprehensive database of relative risk estimates for mortality calculations",
    "data_integrity_note": "All values sourced from peer-reviewed literature and meta-analyses",
    "population_specificity": "U.S.-specific estimates preferred for U.S. baseline mortality calculations. Global estimates clearly marked and should be used with caution.",
    "methodological_note": "Relative risks from global studies may not reflect U.S. population-specific risk due to differences in healthcare access, smoking patterns, and population demographics."
  },
  "smoking": {
    "description": "Relative risks for smoking status on all-cause mortality",
    "source": "Jha et al. (2013) - U.S. specific, GBD 2019 - Global reference",
    "notes": "U.S.-specific estimates preferred for U.S. baseline mortality calculations. Global estimates may over/underestimate risk due to population differences.",
    "values": {
      "current_vs_never": {
        "value": 2.3,
        "source": "Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. NEJM 2013",
        "url": "https://www.nejm.org/doi/full/10.1056/NEJMsa1211128",
        "study_type": "prospective cohort",
        "sample_size": "216,917 U.S. adults",
        "confidence_interval": "2.1-2.5",
        "notes": "U.S.-specific estimate for current smokers vs never smokers. Age-adjusted relative risk for all-cause mortality in U.S. population."
      },
      "current_vs_never_global": {
        "value": 2.5,
        "source": "GBD 2019: Global Burden of Disease Study 2019 results",
        "url": "https://www.healthdata.org/gbd/2019",
        "study_type": "meta-analysis",
        "sample_size": "Global population",
        "confidence_interval": "2.3-2.7",
        "notes": "Global estimate - may not reflect U.S. population-specific risk. Use with caution for U.S. calculations."
      },
      "former_vs_never": {
        "value": 1.2,
        "source": "Doll R, Peto R. Mortality in relation to smoking: 50 years' observations on British doctors. BMJ 2005",
        "url": "https://www.bmj.com/content/330/7495/1519",
        "study_type": "prospective cohort",
        "sample_size": "34,439 British doctors",
        "confidence_interval": "1.1-1.3",
        "notes": "Risk for former smokers vs never smokers"
      },
      "years_to_never_equivalent": {
        "value": 15,
        "source": "Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. NEJM 2013",
        "url": "https://www.nejm.org/doi/full/10.1056/NEJMsa1211128",
        "study_type": "prospective cohort",
        "sample_size": "216,917 adults",
        "confidence_interval": "12-18",
        "notes": "Years after quitting to reach never-smoker risk levels"
      }
    }
  },
  "blood_pressure": {
    "description": "Relative risks for systolic blood pressure on cardiovascular mortality",
    "source": "Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality. Lancet 2002",
    "notes": "Each 20 mmHg increase in SBP doubles cardiovascular mortality risk. Treatment reduces risk by ~30%.",
    "values": {
      "per_20mmhg_sbp": {
        "value": 1.8,
        "source": "Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002",
        "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)11911-8/fulltext",
        "study_type": "meta-analysis",
        "sample_size": "1,000,000 adults",
        "confidence_interval": "1.7-1.9",
        "notes": "Relative risk per 20 mmHg increase in systolic blood pressure"
      },
      "treatment_reduction": {
        "value": 0.7,
        "source": "Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016",
        "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31919-5/fulltext",
        "study_type": "meta-analysis",
        "sample_size": "613,815 participants",
        "confidence_interval": "0.65-0.75",
        "notes": "30% reduction in cardiovascular events with antihypertensive treatment"
      }
    }
  },
  "bmi": {
    "description": "Relative risks for body mass index on all-cause mortality",
    "source": "Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies. Lancet 2016",
    "notes": "J-shaped relationship with optimal BMI around 22-25. Risk increases with both underweight and overweight.",
    "values": {
      "per_5_units": {
        "value": 1.15,
        "source": "Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 2016",
        "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30175-1/fulltext",
        "study_type": "meta-analysis",
        "sample_size": "10,625,411 adults",
        "confidence_interval": "1.13-1.17",
        "notes": "Relative risk per 5-unit increase in BMI above optimal range"
      },
      "optimal_range": {
        "value": [
          22.0,
          24.9
        ],
        "source": "Same as above - Global BMI Mortality Collaboration",
        "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30175-1/fulltext",
        "study_type": "meta-analysis",
        "sample_size": "10,625,411 adults",
        "confidence_interval": "21.5-25.5",
        "notes": "Optimal BMI range for lowest mortality risk"
      }
    }
  },
  "fitness": {
    "description": "Relative risks for cardiorespiratory fitness on all-cause mortality",
    "source": "Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women. JAMA 2009",
    "notes": "Each MET improvement reduces mortality risk by ~10-15%. Sedentary lifestyle increases risk significantly.",
    "values": {
      "per_met": {
        "value": 0.85,
        "source": "Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009",
        "url": "https://jamanetwork.com/journals/jama/fullarticle/184681",
        "study_type": "meta-analysis",
        "sample_size": "102,980 adults",
        "confidence_interval": "0.82-0.88",
        "notes": "15% reduction in mortality risk per MET improvement"
      },
      "sedentary_vs_active": {
        "value": 1.4,
        "source": "Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ 2006",
        "url": "https://www.cmaj.ca/content/174/6/801",
        "study_type": "systematic review",
        "sample_size": "Multiple studies",
        "confidence_interval": "1.3-1.5",
        "notes": "40% higher mortality risk for sedentary vs active individuals"
      }
    }
  },
  "alcohol": {
    "description": "Relative risks for alcohol consumption on all-cause mortality",
    "source": "GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries. Lancet 2018",
    "notes": "Earlier J-curve findings (moderate drinking protective) now understood to be confounded. Mendelian randomization studies show no safe level of alcohol.",
    "values": {
      "moderate_vs_none": {
        "value": 1.0,
        "source": "GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016. Lancet 2018; Millwood IY et al. Conventional and genetic evidence on alcohol and vascular disease. Lancet 2019",
        "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31310-2/fulltext",
        "study_type": "systematic review + Mendelian randomization",
        "sample_size": "Global population",
        "confidence_interval": "0.95-1.05",
        "notes": "No net mortality benefit from moderate alcohol - earlier J-curve findings likely due to sick-quitter bias and confounding"
      },
      "heavy_vs_none": {
        "value": 1.3,
        "source": "Same as above - Di Castelnuovo et al.",
        "url": "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/410298",
        "study_type": "meta-analysis",
        "sample_size": "1,015,835 adults",
        "confidence_interval": "1.2-1.4",
        "notes": "30% higher mortality risk with heavy alcohol consumption"
      },
      "binge_vs_none": {
        "value": 1.2,
        "source": "Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol 2010",
        "url": "https://academic.oup.com/aje/article/171/6/633/108030",
        "study_type": "meta-analysis",
        "sample_size": "Multiple studies",
        "confidence_interval": "1.1-1.3",
        "notes": "20% higher mortality risk with binge drinking patterns"
      }
    }
  },
  "interventions": {
    "description": "Effect sizes for lifestyle interventions on mortality risk",
    "source": "Various meta-analyses and systematic reviews",
    "notes": "Effect sizes for major lifestyle interventions based on clinical trials and cohort studies.",
    "values": {
      "quit_smoking": {
        "value": 0.8,
        "source": "Doll R, Peto R. Mortality in relation to smoking: 50 years' observations on British doctors. BMJ 2005",
        "url": "https://www.bmj.com/content/330/7495/1519",
        "study_type": "prospective cohort",
        "sample_size": "34,439 British doctors",
        "confidence_interval": "0.75-0.85",
        "notes": "20% immediate reduction in mortality risk upon quitting smoking"
      },
      "reduce_bp_10mmhg": {
        "value": 0.85,
        "source": "Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2016",
        "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31919-5/fulltext",
        "study_type": "meta-analysis",
        "sample_size": "613,815 participants",
        "confidence_interval": "0.80-0.90",
        "notes": "15% reduction in mortality risk per 10 mmHg SBP reduction"
      },
      "improve_fitness": {
        "value": 0.9,
        "source": "Kodama S, Saito K, Tanaka S, et al. JAMA 2009",
        "url": "https://jamanetwork.com/journals/jama/fullarticle/184681",
        "study_type": "meta-analysis",
        "sample_size": "102,980 adults",
        "confidence_interval": "0.85-0.95",
        "notes": "10% reduction in mortality risk per MET improvement"
      },
      "lose_weight_5bmi": {
        "value": 0.9,
        "source": "Global BMI Mortality Collaboration. Lancet 2016",
        "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30175-1/fulltext",
        "study_type": "meta-analysis",
        "sample_size": "10,625,411 adults",
        "confidence_interval": "0.85-0.95",
        "notes": "10% reduction in mortality risk per 5 BMI units lost"
      }
    }
  }
}